Literature DB >> 7159418

Characterization of a 40 residue peptide from a human pancreatic tumor with growth hormone releasing activity.

F S Esch, P Böhlen, N C Ling, P E Brazeau, W B Wehrenberg, M O Thorner, M J Cronin, R Guillemin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7159418     DOI： 10.1016/0006-291x(82)91578-9

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN： 0006-291X            Impact factor:   3.575


× No keyword cloud information.
  11 in total

Review 1.  Growth hormone, 1988.

Authors:  M O Thorner; M L Vance
Journal:  J Clin Invest       Date:  1988-09       Impact factor: 14.808

2.  Synthetic human growth hormone releasing factor (h-GRF-I-44-NH2) dose response effect on growth hormone and prolactin secretion in healthy adult men.

Authors:  J P Boissel; R Cohen; S Biot-Laporte; B Claustrat; H Renard; M Olivier; G Sassolas
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

3.  Assessment of pituitary function.

Authors:  T D Hockaday
Journal:  Br Med J (Clin Res Ed)       Date:  1983-12-10

4.  Human pancreatic tumor GH-releasing factor.

Authors:  M O Thorner; W S Evans; M Vance; J L Borges; R M Blizzard; A D Rogol; R M MacLeod; M J Cronin; L A Frohman; J L Thominet
Journal:  Acta Neurochir (Wien)       Date:  1985       Impact factor: 2.216

Review 5.  Neuroendocrine tumors secreting growth hormone-releasing hormone: Pathophysiological and clinical aspects.

Authors:  Monica Gola; Mauro Doga; Stefania Bonadonna; Gherardo Mazziotti; Pier Paolo Vescovi; Andrea Giustina
Journal:  Pituitary       Date:  2006       Impact factor: 4.107

6.  Metabolic clearance and plasma disappearance rates of human pancreatic tumor growth hormone releasing factor in man.

Authors:  L A Frohman; J L Thominet; C B Webb; M L Vance; H Uderman; J Rivier; W Vale; M O Thorner
Journal:  J Clin Invest       Date:  1984-05       Impact factor: 14.808

7.  Growth-hormone releasing factor does not antagonize somatostatin effects on pancreatic and gastric secretions.

Authors:  M Chovet; M Dubrasquet; J Chariot; C Rozé
Journal:  Experientia       Date:  1985-11-15

8.  Isolation, primary structure, and synthesis of human hypothalamic somatocrinin: growth hormone-releasing factor.

Authors:  N Ling; F Esch; P Böhlen; P Brazeau; W B Wehrenberg; R Guillemin
Journal:  Proc Natl Acad Sci U S A       Date:  1984-07       Impact factor: 11.205

9.  Levels of human and rat hypothalamic growth hormone-releasing factor as determined by specific radioimmunoassay systems.

Authors:  T Audhya; M M Manzione; T Nakane; N Kanie; J Passarelli; M Russo; C S Hollander
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

10.  Abnormalities of growth hormone release in response to human pancreatic growth hormone releasing factor (GRF (1-44) ) in acromegaly and hypopituitarism.

Authors:  S M Wood; J L Ch'ng; E F Adams; J D Webster; G F Joplin; K Mashiter; S R Bloom
Journal:  Br Med J (Clin Res Ed)       Date:  1983-05-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.